Status:
UNKNOWN
Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients
Lead Sponsor:
University of Colorado, Denver
Conditions:
End Stage Liver DIsease
Obesity
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This study is being conducted to assess the safety of Direct Peritoneal Resuscitation (DPR) in high-risk liver transplant patients. The investigators want to also identify if this method of recovery a...
Detailed Description
The central hypothesis of this study is that direct peritoneal resuscitation is a safe therapy following liver transplantation and is associated with a reduced rate of return to the operating room. A...
Eligibility Criteria
Inclusion
- Adult liver transplant recipients ≥18 y/o
- Ability to consent
- Pre-operative Creatinine ≥1.1 (or on dialysis) and BMI ≥30
Exclusion
- Diaphragmatic injury
- Active spontaneous bacterial peritonitis (SBP) with initiation of antibiotic treatment within 72 hours of surgery
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05195125
Start Date
February 1 2022
End Date
December 1 2023
Last Update
June 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCHealth - Anschutz Medical Campus
Aurora, Colorado, United States, 80045